Cargando…
Brain Delivery of Curcumin Through Low-Intensity Ultrasound-Induced Blood–Brain Barrier Opening via Lipid-PLGA Nanobubbles
BACKGROUND: Parkinson’s disease (PD) is a progressive neurodegenerative disorder. Owing to the presence of blood–brain barrier (BBB), conventional pharmaceutical agents are difficult to the diseased nuclei and exert their action to inhibit or delay the progress of PD. Recent literatures have demonst...
Autores principales: | Yan, Yiran, Chen, Yan, Liu, Zhongxun, Cai, Feiyan, Niu, Wanting, Song, Liming, Liang, Haifeng, Su, Zhiwen, Yu, Bo, Yan, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575349/ https://www.ncbi.nlm.nih.gov/pubmed/34764649 http://dx.doi.org/10.2147/IJN.S327737 |
Ejemplares similares
-
The effect of transcranial focused ultrasound target location on the acoustic feedback control performance during blood-brain barrier opening with nanobubbles
por: Cheng, Bingbing, et al.
Publicado: (2019) -
PEGylated PLGA-based phase shift nanodroplets combined with focused ultrasound for blood brain barrier opening in rats
por: Zhang, Xiang, et al.
Publicado: (2017) -
Targeted Delivery of Liposomal Temozolomide Enhanced Anti-Glioblastoma Efficacy through Ultrasound-Mediated Blood–Brain Barrier Opening
por: Song, Zhuqing, et al.
Publicado: (2021) -
Lipid-Coated Nanobubbles in Plants
por: Ingram, Stephen, et al.
Publicado: (2023) -
Apatinib-loaded lipid nanobubbles combined with ultrasound-targeted nanobubble destruction for synergistic treatment of HepG2 cells in vitro
por: Tian, Yuhang, et al.
Publicado: (2018)